-
Press release - 03/05/2021
The amount of plastic waste increases every year. Some of this waste is due to plastic packaging used to protect food. As part of the “BioActiveMaterials” project, researchers at the Fraunhofer-Gesellschaft have developed an eco-friendly coating for paper packaging. With this, not only is plastic saved, but the coating of plant-based proteins and waxes also extends the shelf life of the food.
https://www.biooekonomie-bw.de/en/articles/pm/bioactive-paper-coatings-replace-plastic-packaging-foods
-
-
Alternative source of protein - 07/04/2021
It is estimated that by 2050, if not before, the world's population will have grown so much that it will be difficult to provide adequate supplies of food for everyone. It is therefore high time to look for alternatives. One option could be insects as an environmentally friendly source of protein for humans and animals. The start-up company Cepri is developing smart insect farms with the goal to make primary production, which is not yet…
https://www.biooekonomie-bw.de/en/articles/news/smart-insect-farms-sustainable-protein-sources-future
-
-
-
-
-
-
-
-
-
-
-
-
Article - 14/01/2021
Non-coding RNA (ncRNAs) molecules that do not encode proteins have many different functions, and some are associated with certain diseases. Prof. Dr. Sven Diederichs from the German Consortium for Translational Cancer Research and the German Cancer Research Center in Heidelberg has been conducting research into these molecules at the Freiburg University Medical Centre and discovered a ncRNA that regulates cell proliferation in cancer cells.
https://www.gesundheitsindustrie-bw.de/en/article/news/newly-discovered-rna-growth-driver-liver-cancer
-
-
Development of biogenic packaging - 16/11/2020
Modern packaging often boils down to a tick list of biogenic origin and/or biodegradability. But comprehensive sustainable packaging concepts need more than just that. Perishable foods, for example, require special barrier properties. The Albstadt-Sigmaringen University of Applied Sciences is researching packaging concepts for their sustainability.
https://www.biooekonomie-bw.de/en/articles/news/sustainable-packaging-devil-detail
-
-
Atriva Therapeutics - 21/10/2020
The effective treatment of people with severe COVID-19 is a major goal during the corona pandemic. ATR-002, an oral small molecule that targets RNA viruses such as influenza virus and SARS-CoV-2, has a dual effect: it impairs viral propagation and also has an immunomodulatory effect. And what’s more, due to its unique cellular mechanism of action, the efficacy of Atrivia Therapeutics’ drug candidate is not reduced by virus mutations and…
https://www.gesundheitsindustrie-bw.de/en/article/news/covid-19-pioneer-drug-phase-ii-clinical-trial-double-power
-
KyooBe Tech GmbH - 08/10/2020
For decades, conventional inactivated vaccines have been produced by killing pathogens with toxic chemicals. However, this process often changes the surface structure of the pathogens to such an extent that the immune system is only able to induce a weak response. KyooBe Tech GmbH is offering a method that uses low-energy electrons to inactivate pathogens. Vaccines produced this way are much higher quality, making them safer and more effective.
https://www.gesundheitsindustrie-bw.de/en/article/news/next-generation-vaccine-production
-
-
Phytopharmaceuticals - 14/09/2020
Anyone who thinks hemp is just an inconspicuous plant, whose ingredients can be used, at best, as an intoxicant, can quickly be proven wrong. Besides being used as a valuable raw material for textiles and building materials, the plant has great potential as a medicinal drug. The CANNABIS-NET network, coordinated by the University of Hohenheim, has been set up to establish the basis for producing medicinal hemp in Germany.
https://www.gesundheitsindustrie-bw.de/en/article/news/medicinal-cannabis-be-grown-germany
-
Trenzyme GmbH - 20/05/2020
The SARS-CoV-2 coronavirus uses a spike protein to bind to the ACE2 receptor on the cell surfaces of lung tissue. Additional cofactors are needed to allow the virus genome to penetrate human cells and multiply. Knowing these relationships can help understand the course of the infection and develop counterstrategies. To this end, the Constance-based company Trenzyme has produced a recombinant spike protein to support coronavirus research.
https://www.gesundheitsindustrie-bw.de/en/article/news/the-sars-cov-spike-protein-and-its-receptor
-
Fraunhofer Institute for Interfacial Engineering and Biotechnology IGB - 24/04/2020
Every year, around 11 million people die of sepsis (blood poisoning) caused by microorganisms or microbial residues, known as pyrogens, entering the bloodstream. The smallest amounts can trigger fever. Researchers from the Fraunhofer Institute for Interfacial Engineering and Biotechnology IGB in Stuttgart have developed a pyrogen test that does not require a laboratory and is not tested on animals. It is expected to be placed on the market soon.
https://www.gesundheitsindustrie-bw.de/en/article/news/A-rapid-pyrogen-test-the-human-immune-system-as-model
-
Website address: https://www.biooekonomie-bw.de/en/search